Thromboembolic risk stratification in atrial fibrillation—beyond clinical risk scores

• Main Authors: Darryl Wan, Jason Andrade, Zachary Laksman
• Format: Article
• Language: English
• Published: IMR (Innovative Medical Research) Press Limited 2021-06-01
• Series: Reviews in Cardiovascular Medicine
• Subjects: atrial fibrillation; stroke; risk scores
• Online Access: https://rcm.imrpress.com/fileup/2153-8174/PDF/1625013556471-2018851427.pdf

Atrial fibrillation (AF) is the most common arrhythmia in the adult general population. As populations age, the global burden of AF is expected to rise. AF is associated with stroke and thromboembolic complications, which contribute to significant morbidity and mortality. As a result, it remains paramount to identify patients at elevated risk of thromboembolism and to determine who will benefit from thromboembolic prophylaxis. Conventional practice advocates the use of clinical risk scoring criteria to identify patients at risk of thromboembolic complications. These risk scores have modest discriminatory ability in many sub-populations of patients with AF, highlighting the need for improved risk stratification tools. New insights have been gained on the utility of biomarkers and imaging modalities, and there is emerging data on the importance of the identification and treatment of subclinical AF. Finally, the advent of wearable devices to detect cardiac arrhythmias pose a new and evolving challenge in the practice of cardiology. This review aims to address strategies to enhance thromboembolic risk stratification and identify challenges with current and future practice.